
Stereotactic body radiotherapy shows benefits in advanced liver cancer
Add Stereotactic body radiation therapy (SBRT) seems to provide a survival benefit to patients with advanced hepatocellular carcinoma (HCC), especially those with macrovascular invasion. This is the result of a clinical trial of phase 3 presented at the annual meeting of the American Society for Radiation Oncology. The current standard of care for unresectable HCC […]